Regeneron Pharmaceuticals, Inc. (REGN)
799.08
+4.89
(+0.62%)
USD |
NASDAQ |
Aug 31, 16:00
798.97
-0.11
(-0.01%)
After-Hours: 04:52
Regeneron Pharmaceuticals Total Long Term Debt (Quarterly) : 2.707B for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.707B |
| March 31, 2026 | 2.706B |
| December 31, 2025 | 2.935B |
| September 30, 2025 | 2.706B |
| June 30, 2025 | 2.705B |
| March 31, 2025 | 2.705B |
| December 31, 2024 | 2.908B |
| September 30, 2024 | 2.704B |
| June 30, 2024 | 2.704B |
| March 31, 2024 | 2.703B |
| December 31, 2023 | 2.703B |
| September 30, 2023 | 2.703B |
| June 30, 2023 | 2.702B |
| March 31, 2023 | 2.702B |
| December 31, 2022 | 2.701B |
| September 30, 2022 | 2.701B |
| June 30, 2022 | 2.701B |
| March 31, 2022 | 2.700B |
| December 31, 2021 | 2.700B |
| September 30, 2021 | 2.699B |
| June 30, 2021 | 2.698B |
| March 31, 2021 | 2.697B |
| December 31, 2020 | 2.696B |
| September 30, 2020 | 2.695B |
| June 30, 2020 | 715.90M |
| Date | Value |
|---|---|
| March 31, 2020 | 715.20M |
| December 31, 2019 | 713.90M |
| September 30, 2019 | 712.70M |
| June 30, 2019 | 711.30M |
| March 31, 2019 | 709.90M |
| December 31, 2018 | 708.50M |
| September 30, 2018 | 707.20M |
| June 30, 2018 | 705.90M |
| March 31, 2018 | 704.64M |
| December 31, 2017 | 703.45M |
| September 30, 2017 | 702.32M |
| June 30, 2017 | 701.17M |
| March 31, 2017 | 707.61M |
| December 31, 2016 | 478.84M |
| September 30, 2016 | 382.23M |
| June 30, 2016 | 361.52M |
| March 31, 2016 | 362.23M |
| December 31, 2015 | 362.92M |
| September 30, 2015 | 394.87M |
| June 30, 2015 | 388.05M |
| March 31, 2015 | 472.48M |
| December 31, 2014 | 457.71M |
| September 30, 2014 | 565.31M |
| June 30, 2014 | 517.85M |
| March 31, 2014 | 531.11M |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 2.942B |
| AbbVie, Inc. | 70.82B |
| Gilead Sciences, Inc. | 26.25B |
| Amgen, Inc. | 57.30B |
| Biogen, Inc. | 8.355B |